Not finding it? Sign in to also search OpenAlex live.
-
A fast and robust approach for simulating the pressure diffusion in three-dimensional discrete fracture networks applied to inversion problems2020 conference-abstract Environmental Science Groundwater flow and contamination studies Open access
Lisa Maria Ringel, Márk Somogyvári, Mohammadreza Jalali, Peter Bayer
0citations -
ABSTRACT NUMBER: ESOC2026A168 EARLY VERSUS LATE MRI FOR DETECTION OF POSTERIOR CIRCULATION STROKE IN ACUTE ISOLATED CONTINUOUS DIZZINESS: RESULTS OF THE PROVIDE STUDY2026 European Stroke Journal conference-abstract Medicine Acute Ischemic Stroke Management Open access
Merel J J Verhagen, Adriaan Ros, Vincent W. Klokman, Kim Jie, Meike Schoenmakers, Karlijn de Laat, +2 more
0citations -
An Analysis of Capacitive Contributions of the Cell Impedance during High-Temperature CO2 and Co-Electrolysis2023 ECS Meeting Abstracts conference-abstract Materials Science Advancements in Solid Oxide Fuel Cells
Lucy Dittrich, Izaak C. Vinke, Rüdiger‐A. Eichel, Lambertus G. J. de Haart
0citations -
POS0614 AUTOANTIBODIES DIRECTED AGAINST THE ANGIOTENSIN II TYPE 1 RECEPTOR AND THE ENDOTHELIN-1 TYPE A RECEPTOR IN PATIENTS WITH SYSTEMIC SCLEROSIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Systemic Sclerosis and Related Diseases Open access
Katherine E van der Wouden, Saad Ahmed, Wieke M. van Oostveen, Eva M. Hoekstra, Sophie I E Liem, Tom W. J. Huizinga, +6 more
0citations -
Safety and efficacy of the mutant calreticulin-specific monoclonal antibody INCA033989 as monotherapy or in combination with ruxolitinib in patients (pts) with myelofibrosis (MF): Preliminary results from dose escalation of two global Phase 1 studies
Andrew Charles Perkins, Vincent Ribrag, William E. Shomali, Rosa María Ayala, Claire N. Harrison, Stephen T. Oh, +2 more
14citations -
A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of emactuzumab in patients with tenosynovial giant cell tumor (TANGENT).2025 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access
Hans A. J. Gelderblom, Emanuela Palmerini, Jean‐Yves Blay, Michiel A. J. van de Sande, Javier Martín‐Broto, Raúl Terés, +2 more
4citations -
Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial
Lorenzo Falchi, Anna Sureda, Sirpa Leppä, Joost S.P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, +14 more
12citations -
Epcoritamab SC + R-Mini-CHOP Leads to High Complete Metabolic Response Rates in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Ineligible for Full-Dose R-CHOP: First Disclosure from Arm 8 of the Epcore NHL-2 Trial
Joost S.P. Vermaat, Joshua Brody, Juraj Ďuraš, Yasmin H. Karimi, Chan Yoon Cheah, Justin M. Darrah, +7 more
6citations